49 research outputs found
Inducing safer oblique trees without costs
Decision tree induction has been widely studied and applied. In safety applications, such as determining whether a chemical process is safe or whether a person has a medical condition, the cost of misclassification in one of the classes is significantly higher than in the other class. Several authors have tackled this problem by developing cost-sensitive decision tree learning algorithms or have suggested ways of changing the
distribution of training examples to bias the decision tree learning process so as to take account of costs. A prerequisite for applying such algorithms is the availability of costs of misclassification.
Although this may be possible for some applications, obtaining reasonable estimates of costs of misclassification is not easy in the area of safety.
This paper presents a new algorithm for applications where the cost of misclassifications cannot be quantified, although the cost of misclassification in one class is known to be significantly higher than in another class. The algorithm utilizes linear discriminant analysis to identify oblique relationships between continuous attributes and then carries out an appropriate modification to ensure that the resulting tree errs on the side of safety. The algorithm is evaluated with respect to one of the best known cost-sensitive algorithms (ICET), a well-known oblique decision tree algorithm (OC1) and an algorithm that utilizes robust linear programming
Two photons into \pi^0\pi^0
We perform a theoretical study based on dispersion relations of the reaction
\gamma\gamma\to \pi^0\pi^0 emphasizing the low energy region. We discuss how
the f_0(980) signal emerges in \gamma\gamma\to \pi\pi within the dispersive
approach and how this fixes to a large extent the phase of the isoscalar S-wave
\gamma\gamma\to \pi\pi amplitude above the K\bar{K} threshold. This allows us
to make sharper predictions for the cross section at lower energies and our
results could then be used to distinguish between different \pi\pi isoscalar
S-wave parameterizations with the advent of new precise data on
\gamma\gamma\to\pi^0\pi^0. We compare our dispersive approach with an updated
calculation employing Unitary Chiral Perturbation Theory (U\chiPT). We also pay
special attention to the role played by the \sigma resonance in
\gamma\gamma\to\pi\pi and calculate its coupling and width to gamma\gamma, for
which we obtain \Gamma(\sigma\to\gamma\gamma)=(1.68\pm 0.15) KeV.Comment: 31 pages, 9 figure
Measurement of the Charged Multiplicities in b, c and Light Quark Events from Z0 Decays
Average charged multiplicities have been measured separately in , and
light quark () events from decays measured in the SLD experiment.
Impact parameters of charged tracks were used to select enriched samples of
and light quark events, and reconstructed charmed mesons were used to select
quark events. We measured the charged multiplicities:
,
, from
which we derived the differences between the total average charged
multiplicities of or quark events and light quark events: and . We compared
these measurements with those at lower center-of-mass energies and with
perturbative QCD predictions. These combined results are in agreement with the
QCD expectations and disfavor the hypothesis of flavor-independent
fragmentation.Comment: 19 pages LaTex, 4 EPS figures, to appear in Physics Letters
Measurement of Exclusive rho+rho- Production in Mid-Virtuality Two-Photon Interactions and Study of the gamma gamma* -> rho rho Process at LEP
Exclusive rho+rho- production in two-photon collisions between a quasi-real
photon, gamma, and a mid-virtuality photon, gamma*, is studied with data
collected at LEP at centre-of-mass energies root(s)=183-209GeV with a total
integrated luminosity of 684.8pb^-1. The cross section of the gamma gamma* ->
rho+ rho- process is determined as a function of the photon virtuality, Q^2,
and the two-photon centre-of-mass energy, W_gg, in the kinematic region:
0.2GeV^2 < Q^2 <0.85GeV^2 and 1.1GeV < W_gg < 3GeV. These results, together
with previous L3 measurements of rho0 rho0 and rho+ rho- production, allow a
study of the gamma gamma* -> rho rho process over the Q^2-region 0.2GeV^2 < Q^2
< 30 GeV^2
Recent abacavir use increases risk of type 1 and type 2 myocardial infarctions among adults with HIV
Background: There is persistent confusion as to whether abacavir (ABC) increases the risk of myocardial infarction (MI), and whether such risk differs by type 1 (T1MI) or 2 (T2MI) MI in adults with HIV. Methods: Incident MIs in North American Cohort Collaboration on Research and Design participants were identified from 2001 to 2013. Discrete time marginal structural models addressed channeling biases and time-dependent confounding to estimate crude hazard ratio (HR) and adjusted hazard ratio (aHR) and 95% confidence intervals; analyses were performed for T1MI and T2MI separately. A sensitivity analysis evaluated whether Framingham risk score (FRS) modified the effect of ABC on MI occurrence. Results: Eight thousand two hundred sixty-five adults who initiated antiretroviral therapy contributed 29,077 person-years and 123 MI events (65 T1MI and 58 T2MI). Median follow-up time was 2.9 (interquartile range 1.4-5.1) years. ABC initiators were more likely to have a history of injection drug use, hepatitis C virus infection, hypertension, diabetes, impaired kidney function, hyperlipidemia, low (,200 cells/mm3) CD4 counts, and a history of AIDS. The risk of the combined MI outcome was greater for persons who used ABC in the previous 6 months [aHR = 1.84 (1.17-2.91)]; and persisted for T1MI (aHR = 1.62 [1.01]) and T2MI [aHR = 2.11 (1.08-4.29)]. FRS did not modify the effect of ABC on MI (P = 0.14) and inclusion of FRS in the MSM did not diminish the effect of recent ABC use on the combined outcome. Conclusions: Recent ABC use was associated with MI after adjustment for known risk factors and for FRS. However, screening for T1MI risks may not identify all or even most persons at risk of ABC use-associated MIs
Proton-Antiproton Pair Production in Two-Photon Collisions at LEP
The reaction e^+e^- -> e^+e^- proton antiproton is studied with the L3
detector at LEP. The analysis is based on data collected at e^+e^-
center-of-mass energies from 183 GeV to 209 GeV, corresponding to an integrated
luminosity of 667 pb^-1. The gamma gamma -> proton antiproton differential
cross section is measured in the range of the two-photon center-of-mass energy
from 2.1 GeV to 4.5 GeV. The results are compared to the predictions of the
three-quark and quark-diquark models
Search for Colour Singlet and Colour Reconnection Effects in Hadronic Z Decays at LEP
A search is performed in symmetric 3-jet hadronic Z decay events for evidence
of colour singlet production or colour reconnection effects. Asymmetries in the
angular separation of particles are found to be sensitive indicators of such
effects. Upper limits on the level of colour singlet production and colour
reconnection effects are established for a variety of models
Measurement of Exclusive rho^0 rho^0 Production in Mid-Virtuality Two-Photon Interactions at LEP
Exclusive rho^0 rho^0 production in two-photon collisions between a
quasi-real and a mid-virtuality photon is studied with data collected at LEP at
centre-of-mass energies 183GeV < sqrt{s} < 209GeV with a total integrated
luminosity of 684.8/pb. The cross section of the process gamma gamma* -> rho^0
rho^0 is determined as a function of the photon virtuality, q^2, and the
two-photon centre-of-mass energy, Wgg, in the kinematic region: 0.2GeV^2 < q^2
< 0.85GeV^2 and 1.1GeV < Wgg < 3GeV
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
Background: Adults with HIV have an increased burden of non-AIDS-defining cancers, myocardial infarction, end-stage liver disease, and end-stage renal disease. The objective of this study was to estimate the population attributable fractions (PAFs) of preventable or modifiable HIV-related and traditional risk factors for non-AIDS-defining cancers, myocardial infarction, end-stage liver disease, and end-stage renal disease outcomes. Methods: We included participants receiving care in academic and community-based outpatient HIV clinical cohorts in the USA and Canada from Jan 1, 2000, to Dec 31, 2014, who contributed to the North American AIDS Cohort Collaboration on Research and Design and who had validated non-AIDS-defining cancers, myocardial infarction, end-stage liver disease, or end-stage renal disease outcomes. Traditional risk factors were tobacco smoking, hypertension, elevated total cholesterol, type 2 diabetes, renal impairment (stage 4 chronic kidney disease), and hepatitis C virus and hepatitis B virus infections. HIV-related risk factors were low CD4 count (400 copies per mL), and history of a clinical AIDS diagnosis. PAFs and 95% CIs were estimated to quantify the proportion of outcomes that could be avoided if the risk factor was prevented. Findings: In each of the study populations for the four outcomes (1405 of 61 500 had non-AIDS-defining cancer, 347 of 29 515 had myocardial infarctions, 387 of 35 044 had end-stage liver disease events, and 255 of 35 620 had end-stage renal disease events), about 17% were older than 50 years at study entry, about 50% were non-white, and about 80% were men. Preventing smoking would avoid 24% (95% CI 13–35) of these cancers and 37% (7–66) of the myocardial infarctions. Preventing elevated total cholesterol and hypertension would avoid the greatest proportion of myocardial infarctions: 44% (30–58) for cholesterol and 42% (28–56) for hypertension. For liver disease, the PAF was greatest for hepatitis C infection (33%; 95% CI 17–48). For renal disease, the PAF was greatest for hypertension (39%; 26–51) followed by elevated total cholesterol (22%; 13–31), detectable HIV RNA (19; 9–31), and low CD4 cell count (13%; 4–21). Interpretation: The substantial proportion of non-AIDS-defining cancers, myocardial infarction, end-stage liver disease, and end-stage renal disease outcomes that could be prevented with interventions on traditional risk factors elevates the importance of screening for these risk factors, improving the effectiveness of prevention (or modification) of these risk factors, and creating sustainable care models to implement such interventions during the decades of life of adults living with HIV who are receiving care. Funding: National Institutes of Health, US Centers for Disease Control and Prevention, the US Agency for Healthcare Research and Quality, the US Health Resources and Services Administration, the Canadian Institutes of Health Research, the Ontario Ministry of Health and Long Term Care, and the Government of Alberta
Measurement of Exclusive \rho^+\rho^- Production in High-Q^2 Two-Photon Collisions at LEP
Exclusive rho^+ rho^- production in two-photon collisions involving a single
highly-virtual photon is studied with data collected at LEP at centre-of-mass
energies 89 GeV < \sqrt{s} < 209 GeV with a total integrated luminosity of
854.7 pb^-1. The cross section of the process gamma gamma^* -> rho^+ rho^- is
determined as a function of the photon virtuality, Q^2, and the two-photon
centre-of-mass energy, W_gg, in the kinematic region: 1.2 GeV^2 < Q^2 < 30
GeV^2 and 1.1 GeV < W_gg < 3 GeV. The \rho^+\rho^- production cross section is
found to be of the same magnitude as the cross section of the process gamma
gamma^* -> rho^0 rho^0, measured in the same kinematic region by L3, and to
have similar W_gg and Q^2 dependences